Citalopram, QTc Interval Prolongation, and Torsade de Pointes. How Should We Apply the Recent FDA Ruling?
The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Atypical antipsychotic drugs and the risk of sudden cardiac death
Ray, W. A., Chung, C. P., Murray, K. T., Hall, K., & Stein, C. M. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0806994 · Cited by 1,194
The STAR*D project results: A comprehensive review of findings
Warden, D., Rush, A. J., Trivedi, M. H., Fava, M., & Wisniewski, S. R. (2007) · Current Psychiatry Reports · doi:10.1007/s11920-007-0061-3 · Cited by 727
Antipsychotics and the Risk of Sudden Cardiac Death
Ray, W. A., Meredith, S., Thapa, P. B., Meador, K. G., Hall, K., & Murray, K. T. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.12.1161 · Cited by 429
QTc Prolongation by Psychotropic Drugs and the Risk of Torsade de Pointes
Wenzel-Seifert, K., Wittmann, M., & Haen, E. (2011) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2011.0687 · Cited by 256
Indik, J. H., Pearson, E. C., Fried, K., & Woosley, R. L. (2006) · Heart Rhythm · doi:10.1016/j.hrthm.2006.05.023 · Cited by 166
The thorough QT/QTc study 4 years after the implementation of the ICH E14 guidance
Darpo, B. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00487.x · Cited by 141
Assessment of prolonged QT and JT intervals in ventricular conduction defects
Rautaharju, P. M., Zhang, Z.-M., Prineas, R., & HEISS, G. M. (2004) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2003.12.055 · Cited by 135
Zhang, Y., Post, W. S., Dalal, D., Blasco‐Colmenares, E., Tomaselli, G. F., & Güallar, E. (2011) · Archives of Internal Medicine · doi:10.1001/archinternmed.2011.433 · Cited by 130
Proarrhythmic Risk with Antipsychotic and Antidepressant Drugs: Implications in the Elderly
Vieweg, W. V. R., Wood, M. A., Fernandez, A., Beatty-Brooks, M., Hasnain, M., & Pandurangi, A. K. (2009) · Drugs & Aging · doi:10.2165/11318880-000000000-00000 · Cited by 121
Self-citationCardiac Safety of Citalopram: Prospective Trials and Retrospective Analyses
Rasmussen, S. L., Overø, K. F., & Tanghøj, P. (1999) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199910000-00004 · Cited by 104
Cited by
Kennedy, S. H., Lam, R. W., McIntyre, R. S., Tourjman, S. V., Bhat, V., Blier, P., Hasnain, M., Jollant, F., Levitt, A. J., MacQueen, G. M., et al. (2016) · The Canadian Journal of Psychiatry · doi:10.1177/0706743716659417 · Cited by 1,181
Self-citationMalhi, G. S., Bassett, D., Boyce, P., Bryant, R., Fitzgerald, P. B., Fritz, K., Hopwood, M., Lyndon, B., Mulder, R., Murray, G., et al. (2015) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867415617657 · Cited by 842
“Citalopram has been associated with prolonged QTc interval at high doses but clinical relevance is unclear (Vieweg et al., 2012).”
BackgroundBarnes, T. R., Drake, R., Paton, C., Cooper, S. J., Deakin, B., Ferrier, I. N., Gregory, C. J., Haddad, P. M., Howes, O. D., Jones, I., et al. (2020) · Journal of Psychopharmacology · doi:10.1177/0269881119889296 · Cited by 606
QTc Prolongation, Torsades de Pointes, and Psychotropic Medications
Beach, S. R., Celano, C. M., Noseworthy, P. A., Januzzi, J. L., & Huffman, J. C. (2013) · Psychosomatics · doi:10.1016/j.psym.2012.11.001 · Cited by 345
A Comparison of the Risk of QT Prolongation Among SSRIs
Funk, K. A., & Bostwick, J. R. (2013) · Annals of Pharmacotherapy · doi:10.1177/1060028013501994 · Cited by 174
Evaluation of the FDA Warning Against Prescribing Citalopram at Doses Exceeding 40 mg
Zivin, K., Pfeiffer, P. N., Bohnert, A. S. B., Ganoczy, D., Blow, F. C., Nallamothu, B. K., & Kales, H. C. (2013) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2013.12030408 · Cited by 127
Impact of antidepressants on cytokine production of depressed patients in Vitro
Munzer, A., Sack, U., Mergl, R., Schönherr, J., Petersein, C., Bartsch, S., Kirkby, K., Bauer, K., & Himmerich, H. (2013) · Toxins · doi:10.3390/toxins5112227 · Cited by 114
GARABELLI, P., STAVRAKIS, S., ALBERT, M., KOOMSON, E., PARWANI, P., CHOHAN, J., SMITH, L., ALBERT, D., XIE, R., XIE, Q., et al. (2016) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.12976 · Cited by 98
Psychological Distress and Arrhythmia: Risk Prediction and Potential Modifiers
Peacock, J., & Whang, W. (2013) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2013.03.001 · Cited by 73
Cardiovascular adverse effects of newer antidepressants
Mago, R., Tripathi, N., & Andrade, C. (2014) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2014.908709 · Cited by 54
“Didesmethylcitalopram, which was associated with QT prolongation in beagle dogs, is usually a minor metabolite in humans; however, in CPY2D6 ultrarapid metabolizers, its levels may increase, and this may lead to an increased risk of QT prolongation [24].”
Background
Metadata
- Authors
- Vieweg, W. V. R., Hasnain, M., Howland, R. H., Hettema, J. M., Kogut, C., Wood, M. A., & Pandurangi, A. K.
- Venue
- The American Journal of Medicine
- Publisher
- Elsevier BV
- Published
- 2012-09
- Volume
- 125
- Issue
- 9
- Pages
- 859-868
- ISSN
- 0002-9343 (ISSN-L)
- OpenAlex
- W2088722048
- Cited by
- 270
- References
- 27
- FWCI
- 9.02
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.